These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29052492)

  • 21. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.
    Zhang Y; Lin X; Lu F
    Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trimethoprim-Sulfamethoxazole Prophylaxis During Live Malaria Sporozoite Immunization Induces Long-Lived, Homologous, and Heterologous Protective Immunity Against Sporozoite Challenge.
    Hobbs CV; Anderson C; Neal J; Sahu T; Conteh S; Voza T; Langhorne J; Borkowsky W; Duffy PE
    J Infect Dis; 2017 Jan; 215(1):122-130. PubMed ID: 28077589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients.
    Thomas M; Rupali P; Woodhouse A; Ellis-Pegler R
    Scand J Infect Dis; 2009; 41(11-12):862-8. PubMed ID: 19922070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study.
    Creemers-Schild D; Kroon FP; Kuijper EJ; de Boer MG
    Infection; 2016 Jun; 44(3):291-9. PubMed ID: 26471512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
    Ribera E; Fernandez-Sola A; Juste C; Rovira A; Romero FJ; Armadans-Gil L; Ruiz I; Ocaña I; Pahissa A
    Clin Infect Dis; 1999 Dec; 29(6):1461-6. PubMed ID: 10585796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The impact of the prevention of cerebral toxoplasmosis].
    Katlama C
    J Neuroradiol; 1995 Sep; 22(3):193-5. PubMed ID: 7472536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up.
    Fernandes Felix JP; Cavalcanti Lira RP; Cosimo AB; Cardeal da Costa RL; Nascimento MA; Leite Arieta CE
    Am J Ophthalmol; 2016 Oct; 170():176-182. PubMed ID: 27521607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfamethoxazole Levels in HIV-Exposed Uninfected Ugandan Children.
    Kasule J; Gabriel EE; Anok A; Neal J; Eastman RT; Penzak S; Newell K; Serwadda D; Duffy PE; Reynolds SJ; Hobbs CV
    Am J Trop Med Hyg; 2018 Jun; 98(6):1718-1721. PubMed ID: 29692311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.
    Green H; Paul M; Vidal L; Leibovici L
    Mayo Clin Proc; 2007 Sep; 82(9):1052-9. PubMed ID: 17803871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
    Vesterbacka J; Barqasho B; Häggblom A; Nowak P
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):830-6. PubMed ID: 26059763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
    J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissemination of Trimethoprim-Sulfamethoxazole Drug Resistance Genes Associated with Class 1 and Class 2 Integrons Among Gram-Negative Bacteria from HIV Patients in South India.
    Ramesh Kumar MR; Arunagirinathan N; Srivani S; Dhanasezhian A; Vijaykanth N; Manikandan N; Balakrishnan S; Vignesh R; Balakrishnan P; Solomon S; Solomon SS
    Microb Drug Resist; 2017 Jul; 23(5):602-608. PubMed ID: 27854149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis.
    Rungoe C; Malchau EL; Larsen LN; Schroeder H
    Pediatr Blood Cancer; 2010 Aug; 55(2):304-8. PubMed ID: 20583218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis.
    Williams JW; Holleman DR; Samsa GP; Simel DL
    JAMA; 1995 Apr; 273(13):1015-21. PubMed ID: 7897784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.
    Utsunomiya M; Dobashi H; Odani T; Saito K; Yokogawa N; Nagasaka K; Takenaka K; Soejima M; Sugihara T; Hagiyama H; Hirata S; Matsui K; Nonomura Y; Kondo M; Suzuki F; Tomita M; Kihara M; Yokoyama W; Hirano F; Yamazaki H; Sakai R; Nanki T; Koike R; Kohsaka H; Miyasaka N; Harigai M
    Arthritis Res Ther; 2017 Jan; 19(1):7. PubMed ID: 28100282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations.
    Gajurel K; Dhakal R; Montoya JG
    Curr Opin Infect Dis; 2015 Aug; 28(4):283-92. PubMed ID: 26098500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation.
    Mendorf A; Klyuchnikov E; Langebrake C; Rohde H; Ayuk F; Regier M; Christopeit M; Zabelina T; Bacher A; Stübig T; Wolschke C; Bacher U; Kröger N
    Acta Haematol; 2015; 134(3):146-54. PubMed ID: 25968483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of trimethoprim-sulfamethoxazole in HIV-infected patients with cerebral toxoplasmosis in Brazil: a single-arm open-label clinical trial.
    Pellegrino D; Gryschek R; de Oliveira ACP; Marcusso R; Correia A; Vidal JE
    Int J STD AIDS; 2019 Oct; 30(12):1156-1162. PubMed ID: 31558125
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease.
    Vidal JE
    J Int Assoc Provid AIDS Care; 2019; 18():2325958219867315. PubMed ID: 31429353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population.
    McLaughlin MM; Galal A; Richardson CL; Sutton SH; Barr VO; Patel N; Mitchell P; Stosor V
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28833985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.